HR

HR
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $297.765M ▲ | $159.612M ▼ | $-57.738M ▲ | -19.39% ▲ | $-0.17 ▲ | $145.05M ▲ |
| Q2-2025 | $297.502M ▼ | $171.231M ▲ | $-157.851M ▼ | -53.059% ▼ | $-0.45 ▼ | $52.391M ▼ |
| Q1-2025 | $298.977M ▲ | $164.499M ▼ | $-44.873M ▲ | -15.009% ▲ | $-0.13 ▲ | $170.755M ▲ |
| Q4-2024 | $290.609M ▼ | $175.382M ▼ | $-106.846M ▼ | -36.766% ▼ | $-0.31 ▼ | $121.356M ▼ |
| Q3-2024 | $315.423M | $183.35M | $-93.023M | -29.492% | $-0.26 | $175.067M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $43.345M ▲ | $9.86B ▼ | $5.115B ▼ | $4.683B ▼ |
| Q2-2025 | $25.507M ▼ | $10.236B ▼ | $5.354B ▲ | $4.817B ▼ |
| Q1-2025 | $25.722M ▼ | $10.496B ▼ | $5.349B ▲ | $5.078B ▼ |
| Q4-2024 | $68.916M ▲ | $10.651B ▼ | $5.345B ▼ | $5.235B ▼ |
| Q3-2024 | $22.801M | $11.245B | $5.645B | $5.515B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-58.544M ▲ | $113.753M ▼ | $226.275M ▲ | $-322.189M ▼ | $17.838M ▲ | $24.929M ▼ |
| Q2-2025 | $-160.143M ▼ | $163.215M ▲ | $-3.098M ▲ | $-160.181M ▼ | $-215K ▲ | $77.562M ▲ |
| Q1-2025 | $-45.389M ▲ | $47.788M ▼ | $-38.833M ▼ | $-52.149M ▲ | $-43.194M ▼ | $-21.34M ▼ |
| Q4-2024 | $-107.754M ▼ | $138.012M ▲ | $418.655M ▲ | $-513.91M ▼ | $46.115M ▲ | $138.012M ▲ |
| Q3-2024 | $-94.535M | $119.301M | $330.761M | $-465.668M | $-18.964M | $50.334M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
Management Fee Income | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Parking Income | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Healthcare Realty Trust is transitioning from a period of enlargement and merger-driven complexity into a phase focused on cleanup, optimization, and disciplined operations. The properties themselves appear to generate solid cash flow, but recent accounting losses and higher financing burdens have weighed on reported profitability and equity. The balance sheet is still debt‑heavy but is gradually being reshaped through asset sales and more selective investment. Strategically, the company benefits from prime locations, deep hospital relationships, and in‑house operating expertise, all within a resilient niche of healthcare real estate. The main opportunities lie in successfully executing its 2.0 plan—lifting occupancy, recycling capital, and meeting ESG efficiency targets—while the key risks center on balance sheet leverage, interest rates, and the challenge of proving that this strategic overhaul can translate into more durable, visible earnings quality over time.
NEWS
October 30, 2025 · 4:15 PM UTC
Healthcare Realty Reports Third Quarter 2025 Results
Read more
October 14, 2025 · 4:05 PM UTC
Healthcare Realty Trust Announces Third Quarter Earnings Release Date and Conference Call
Read more
October 8, 2025 · 4:05 PM UTC
Healthcare Realty Trust Releases Seventh Corporate Responsibility Report
Read more
About Healthcare Realty Trust Incorporated
https://www.healthcarerealty.comHealthcare Realty Trust is a real estate investment trust that integrates owning, managing, financing and developing income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $297.765M ▲ | $159.612M ▼ | $-57.738M ▲ | -19.39% ▲ | $-0.17 ▲ | $145.05M ▲ |
| Q2-2025 | $297.502M ▼ | $171.231M ▲ | $-157.851M ▼ | -53.059% ▼ | $-0.45 ▼ | $52.391M ▼ |
| Q1-2025 | $298.977M ▲ | $164.499M ▼ | $-44.873M ▲ | -15.009% ▲ | $-0.13 ▲ | $170.755M ▲ |
| Q4-2024 | $290.609M ▼ | $175.382M ▼ | $-106.846M ▼ | -36.766% ▼ | $-0.31 ▼ | $121.356M ▼ |
| Q3-2024 | $315.423M | $183.35M | $-93.023M | -29.492% | $-0.26 | $175.067M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $43.345M ▲ | $9.86B ▼ | $5.115B ▼ | $4.683B ▼ |
| Q2-2025 | $25.507M ▼ | $10.236B ▼ | $5.354B ▲ | $4.817B ▼ |
| Q1-2025 | $25.722M ▼ | $10.496B ▼ | $5.349B ▲ | $5.078B ▼ |
| Q4-2024 | $68.916M ▲ | $10.651B ▼ | $5.345B ▼ | $5.235B ▼ |
| Q3-2024 | $22.801M | $11.245B | $5.645B | $5.515B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-58.544M ▲ | $113.753M ▼ | $226.275M ▲ | $-322.189M ▼ | $17.838M ▲ | $24.929M ▼ |
| Q2-2025 | $-160.143M ▼ | $163.215M ▲ | $-3.098M ▲ | $-160.181M ▼ | $-215K ▲ | $77.562M ▲ |
| Q1-2025 | $-45.389M ▲ | $47.788M ▼ | $-38.833M ▼ | $-52.149M ▲ | $-43.194M ▼ | $-21.34M ▼ |
| Q4-2024 | $-107.754M ▼ | $138.012M ▲ | $418.655M ▲ | $-513.91M ▼ | $46.115M ▲ | $138.012M ▲ |
| Q3-2024 | $-94.535M | $119.301M | $330.761M | $-465.668M | $-18.964M | $50.334M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
Management Fee Income | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Parking Income | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Healthcare Realty Trust is transitioning from a period of enlargement and merger-driven complexity into a phase focused on cleanup, optimization, and disciplined operations. The properties themselves appear to generate solid cash flow, but recent accounting losses and higher financing burdens have weighed on reported profitability and equity. The balance sheet is still debt‑heavy but is gradually being reshaped through asset sales and more selective investment. Strategically, the company benefits from prime locations, deep hospital relationships, and in‑house operating expertise, all within a resilient niche of healthcare real estate. The main opportunities lie in successfully executing its 2.0 plan—lifting occupancy, recycling capital, and meeting ESG efficiency targets—while the key risks center on balance sheet leverage, interest rates, and the challenge of proving that this strategic overhaul can translate into more durable, visible earnings quality over time.
NEWS
October 30, 2025 · 4:15 PM UTC
Healthcare Realty Reports Third Quarter 2025 Results
Read more
October 14, 2025 · 4:05 PM UTC
Healthcare Realty Trust Announces Third Quarter Earnings Release Date and Conference Call
Read more
October 8, 2025 · 4:05 PM UTC
Healthcare Realty Trust Releases Seventh Corporate Responsibility Report
Read more

CEO
Peter A. Scott
Compensation Summary
(Year 2024)

CEO
Peter A. Scott
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2014-12-16 | Reverse | 1:2 |
Ratings Snapshot
Rating : B-
Most Recent Analyst Grades

BTIG
Buy

Scotiabank
Sector Outperform

Wells Fargo
Equal Weight

Citigroup
Neutral

JP Morgan
Neutral

Wedbush
Neutral

Raymond James
Underperform
Grade Summary
Price Target
Institutional Ownership

COHEN & STEERS, INC.
55.561M Shares
$1.013B

BLACKROCK, INC.
53.457M Shares
$974.525M

VANGUARD GROUP INC
47.171M Shares
$859.919M

BLACKROCK INC.
43.72M Shares
$797.008M

STATE STREET CORP
17.907M Shares
$326.437M

PRICE T ROWE ASSOCIATES INC /MD/
15.326M Shares
$279.394M

STARBOARD VALUE LP
14.49M Shares
$264.153M

APG ASSET MANAGEMENT US INC.
12.087M Shares
$220.34M

DAIWA SECURITIES GROUP INC.
10.7M Shares
$195.053M

RUSH ISLAND MANAGEMENT, LP
7.803M Shares
$142.255M

INVESCO LTD.
7.701M Shares
$140.385M

BLACKROCK FUND ADVISORS
7.602M Shares
$138.58M

GEODE CAPITAL MANAGEMENT, LLC
6.952M Shares
$126.735M

CHARLES SCHWAB INVESTMENT MANAGEMENT INC
6.817M Shares
$124.275M

MASSACHUSETTS FINANCIAL SERVICES CO /MA/
6.782M Shares
$123.645M

RESOLUTION CAPITAL LTD
6.402M Shares
$116.71M

DEUTSCHE BANK AG\
5.415M Shares
$98.72M

JPMORGAN CHASE & CO
5.233M Shares
$95.389M

THRIVENT FINANCIAL FOR LUTHERANS
5.018M Shares
$91.479M

DIMENSIONAL FUND ADVISORS LP
5.013M Shares
$91.396M
Summary
Only Showing The Top 20

